Page last updated: 2024-09-05

sb 203580 and bepafant

sb 203580 has been researched along with bepafant in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(bepafant)
Trials
(bepafant)
Recent Studies (post-2010) (bepafant)
3,48941,13717405

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)bepafant (IC50)
Platelet-activating factor receptorCavia porcellus (domestic guinea pig)0.073

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdel-Al, M; Ditmyer, M; Howard, KM; Patel, N1

Other Studies

1 other study(ies) available for sb 203580 and bepafant

ArticleYear
Lipopolysaccharide and platelet-activating factor stimulate expression of platelet-activating factor acetylhydrolase via distinct signaling pathways.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2011, Volume: 60, Issue:8

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Azepines; Cell Line; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Imidazoles; Lipopolysaccharides; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridines; Receptors, G-Protein-Coupled; RNA, Messenger; Triazoles

2011